One in ten Americans, approximately 35 million people, have peripheral neuropathy (PN). This is an epidemic by any definition. Over the past decades…
A recently published paper in the journal Diabetes Therapy, examines the impact of alcohol use in diabetic patients with distal symmetrical…
Summary: Benfotiamine and alpha lipoic acid (ALA) are two of the most commonly used nutrients in the treatment of peripheral…
In order for neurons to successfully perform their primary function of conducting action potentials, their mitochondria produce significantly greater amounts…
Summary: Recent studies indicate that type 2 diabetics with peripheral neuropathy are at increased risk of undergoing cognitive decline and…
A group of investigators from the UK recently performed an extensive review of the scientific literature in an attempt…
Summary: In a ground-breaking study, investigators found that decreased sensation in the foot may be an underrecognized risk factor for…
A new study published in the Journal of Alzheimer’s Disease concludes that oral benfotiamine, a high potency lipid-soluble form of…
Summary: Obstructive sleep apnea (OSA) is a common, independent, and often-overlooked cause of peripheral neuropathy. Additionally, in type 2 diabetics,…
On April 17, 2020, the online New England Journal of Medicine published the correspondence Guillain–Barré Syndrome Associated with SARS-CoV-2. The…